Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by bluemoons20on Dec 26, 2022 9:01am
115 Views
Post# 35191826

RE:RE:RE:Shares for Debt

RE:RE:RE:Shares for DebtWell  , I  guess if there was a time to average down  , now would b it!!  Tax loss season.  However ,on the surprising  side  of  this  look at the  volume.

THERE IS VIRTUALLY  NONE!!   Given the  situation over the last few years  you would think  shares would be trading like  mad.  seems  not many peope want out  and are riding this  one all the  way  down??

Is there something  that  folks here do not  know  or  have people just forgotten this is in their portfolio??  If the shares were held by  one person. they would have to be reported.

There is  still a likelihood that Andrew takes this  private  at some point.  Could make a deal with Yafoto  for  their  shares.

Probel is that then  we  would  be paid out at the  7  Cents  level  (or  lower)!!

Just  hope   we can find  light at the end of the tunnel  but  it is  not looking all that  good.

GLTA
<< Previous
Bullboard Posts
Next >>